Evidence map›Paper›PMID 40781474›Full record

ArticleScientific reports2025

Machine learning based analysis of leucocyte cell population data by Sysmex XN series hematology analyzer for the diagnosis of bacteremia.

Sadashi Horie, Mizuki Yamashita, Kenta Matsumura, Yoji Uejima, Makito Kaneda, Kentaro Nagaoka, Kentaro Tamura, Kenu Harada, Yoshihiro Yamamoto, Isao Kitajima and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sadashi HorieDepartment of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. sadashih@med.u-toyama.ac.jp.
Mizuki YamashitaDepartment of Clinical Laboratory and Transfusion Medicine & Cell Therapy Center, Toyama University Hospital, Toyama, Japan.
Kenta MatsumuraGraduate School of Health Sciences, Aomori University of Health and Welfare, Aomori, Japan.
Yoji UejimaDepartment of Infectious Diseases, Immunology and Allergy, Saitama Prefectural Children's Medical Center, Saitama, Japan.
Makito KanedaDepartment of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kentaro NagaokaDepartment of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kentaro TamuraDepartment of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Kenu HaradaDepartment of Clinical Laboratory and Transfusion Medicine & Cell Therapy Center, Toyama University Hospital, Toyama, Japan.
Yoshihiro YamamotoDepartment of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
Isao KitajimaAdministrative Office, University of Toyama, Toyama, Japan.
Chihaya ImaiDepartment of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Hideki NiimiDepartment of Clinical Laboratory and Transfusion Medicine & Cell Therapy Center, Toyama University Hospital, Toyama, Japan.

Funding

Kaken Pharmaceutical 21H02825
6 · The paper itself

Abstract

In clinical practice, early recognition of bacteremia leads to prognostic improvement. Recently, cell population data (CPD) from the Sysmex XN-series hematology analyzer has attracted attention as a new method for the early diagnosis of bacteremia, but its usefulness in clinical practice remains unclear. We focused on the fluorescent light distribution of the neutrophil area (NE-WY) and used machine learning to determine whether predictions could be improved. Among adult patients with clinically suspected bacteremia at our hospital, 533 who did not meet the exclusion criteria were enrolled. Propensity score matching was performed for bacteremia (n = 106) and non-bacteremia (n = 427) cases. NE-WY showed the largest difference between the two groups (AUC, 0.768; sensitivity, 73.6%; specificity, 67.9%; cutoff value, 686.5(no unit)). In machine learning, the first branch of the decision tree was NE-WY, and the cutoff value was set at 689.5(no unit). Support vector machines were used to examine multiple variables, but there were no significant differences relative to NE-WY alone. This is the first report to demonstrate that NE-WY is useful for detecting bacteremia by analyzing CPD using machine learning. The combination of CPD and machine learning is expected to produce new results.

Indexed as

BacteremiaLeukocytesMachine LearningAdultAgedAged, 80 and overFemaleHumansLeukocyte CountMaleMiddle AgedNeutrophilsBacteremiaCell population datamachine learningNE-WYpropensity score matching

Identifiers

PMID40781474
PMCPMC12334559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.